•  
  •  
  •  
  •  

2025-10-06 05:44:49

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Nykaa Quarterly Revenue Update - Q2 FY2026
  • Utkarsh Small Finance Bank Ltd - Q2FY26 Business Update
  • HCL Infosystems Ltd receives final arbitration award in arbitration filed against UIDAI
  • Bank of Baroda - Q2 FY2026 Business Update
  • JTL Industries report highest ever H1 FY26 Volumes at 1,82,210 MT, records 3.5% YoY growth

Keywords Selected:  INE398R01022

Research

  • Q4FY22 Result Update - Syngene International - ICICI Direct
  • Q3FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Q3FY22 Result First cut - YES Securities
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

Stock Report

  • USFDA conducts GCP inspection at Syngene International Ltd's facility at Semicon Park, Bengaluru
  • Syngene International Ltd updates on USFDA inspection at Biocon Park, SEZ, Bengaluru
  • Syngene International Ltd recommends final dividend of Rs. 1.25
  • Syngene International Limited appoints Mr. Peter Bains as MD & CEO
  • Syngene concludes the acquisition of Biologics Manufacturing Facility from Emergent BioSolutions Inc.
  • Syngene acquires its First Manufacturing Facility in the US
  • Syngene International Ltd updates on USFDA inspection at Bengaluru facilities
  • Syngene International Ltd recommends final dividend of Rs. 1.25
  • Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd
  • Syngene International Ltd recommends final dividend of Rs. 1.25
  • Syngene International Ltd update on USFDA Inspection of Biologics facility
  • Syngene signs 10-year biologics manufacturing agreement with leading animal health company, Zoetis
  • Syngene International Limited recommends final dividend of Rs. 1
  • ICRA places Syngene International's rating under watch
  • Syngene International Ltd updates on independent director
  • Syngene International announces Extension of Collaboration with Amgen

Latest Post

  • Nykaa Quarterly Revenue Update - Q2 FY2026
  • Utkarsh Small Finance Bank Ltd - Q2FY26 Business Update
  • HCL Infosystems Ltd receives final arbitration award in arbitration filed against UIDAI
  • Bank of Baroda - Q2 FY2026 Business Update
  • JTL Industries report highest ever H1 FY26 Volumes at 1,82,210 MT, records 3.5% YoY growth


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024